::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

PROGNOSTIC VALUE OF UNDETECTABLE HS TROPONIN T IN SUSPECTED ACUTE CORONARY SYNDROME

AUTHORS:

Dr Ayesha Siddiqa,Dr Maleeha Mujeeeb Khan, Dr Fareeha Rafiq

ABSTRACT:

Chest pain is one of the most common reasons for an emergency room (ER) visit in the world, with more than 10 million ER visits annually. High-sensitivity cardiac troponin (hscTn) assays have the ability to rapidly rule in or rule out acute coronary syndrome with improved sensitivity, and they are increasingly being used. Though hscTn assays have been approved for use in European, Australian, and Canadian guidelines since 2010, authorities only approved their use in 2017. There is no consensus on how to compare the results from various hscTn assays. A literature review was performed to analyse the advantages and limitations of using hscTn as a standard biomarker to evaluate patients with suspected Acute Coronary Syndrome (ACS) in the emergency setting. Keywords: Acute coronary syndrome, myocardial infarction, troponin, cardiac biomarkers.